An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 020648
Company: BAUSCH

Other Important Information from FDA

Products on NDA 020648

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
DIASTAT	DIAZEPAM	2.5MG/0.5ML (5MG/ML)	GEL;RECTAL	Prescription	None	Yes	Yes
DIASTAT	DIAZEPAM	5MG/ML (5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	GEL;RECTAL	Discontinued	None	Yes	No
DIASTAT	DIAZEPAM	10MG/2ML (5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	GEL;RECTAL	Discontinued	None	Yes	No
DIASTAT	DIAZEPAM	15MG/3ML (5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	GEL;RECTAL	Discontinued	None	Yes	No
DIASTAT	DIAZEPAM	20MG/4ML (5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	GEL;RECTAL	Discontinued	None	Yes	No
DIASTAT ACUDIAL	DIAZEPAM	20MG/4ML (5MG/ML)	GEL;RECTAL	Prescription	AB	Yes	Yes
DIASTAT ACUDIAL	DIAZEPAM	10MG/2ML (5MG/ML)	GEL;RECTAL	Prescription	AB	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 020648

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
07/29/1997	ORIG-1	Approval	Type 3 - New Dosage Form	STANDARD; Orphan		Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
07/10/2023	SUPPL-24	Manufacturing (CMC)-Control	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020648s024lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/020648s024ltr.pdf
01/13/2023	SUPPL-23	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020648s023lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/020648Orig1s023ltr.pdf
03/25/2021	SUPPL-22	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020648s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/020648Orig1s022ltr.pdf
02/05/2021	SUPPL-21	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020648s021lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/020648Orig1s021ltr.pdf
12/16/2016	SUPPL-14	Labeling-Package Insert, Labeling-Medication Guide	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020648s014lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/020648Orig1s014ltr.pdf
10/27/2016	SUPPL-13	Labeling-Container/Carton Labels	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020648s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/020648Orig1s013ltr.pdf
12/16/2014	SUPPL-12	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020648s012lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/020648Orig1s012ltr.pdf
08/29/2013	SUPPL-9	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020648Orig1s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020648Orig1s009ltr.pdf
09/15/2005	SUPPL-8	Manufacturing (CMC)-Control	Label (PDF) Letter (PDF) Patient Package Insert (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020648s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/020648s008ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020648s008ppi.pdf
06/18/2002	SUPPL-5	Manufacturing (CMC)		Label is not available on this site.
10/17/2000	SUPPL-4	Manufacturing (CMC)		Label is not available on this site.
08/31/2000	SUPPL-3	Manufacturing (CMC)		Label is not available on this site.
04/11/2001	SUPPL-2	Labeling	Letter (PDF) Review (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2001/20648S2ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/020648_S002_DIASTAT_AP.pdf
08/25/1998	SUPPL-1	Manufacturing (CMC)-Control		Label is not available on this site.

Labels for NDA 020648

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
07/10/2023	SUPPL-24	Manufacturing (CMC)-Control	Label (PDF)	This supplement type does not usually require new labeling.	https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020648s024lbl.pdf
01/13/2023	SUPPL-23	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020648s023lbl.pdf
03/25/2021	SUPPL-22	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020648s022lbl.pdf
02/05/2021	SUPPL-21	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020648s021lbl.pdf
12/16/2016	SUPPL-14	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020648s014lbl.pdf
12/16/2016	SUPPL-14	Labeling-Medication Guide	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020648s014lbl.pdf
10/27/2016	SUPPL-13	Labeling-Container/Carton Labels	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020648s013lbl.pdf
12/16/2014	SUPPL-12	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020648s012lbl.pdf
08/29/2013	SUPPL-9	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020648Orig1s009lbl.pdf
09/15/2005	SUPPL-8	Manufacturing (CMC)-Control	Label (PDF)	This supplement type does not usually require new labeling.	https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020648s008lbl.pdf

Therapeutic Equivalents for NDA 020648

DIASTAT

There are no Therapeutic Equivalents.

DIASTAT ACUDIAL

GEL;RECTAL; 20MG/4ML (5MG/ML)
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
DIASTAT ACUDIAL	DIAZEPAM	20MG/4ML (5MG/ML)	GEL;RECTAL	Prescription	Yes	AB	020648	BAUSCH
DIAZEPAM	DIAZEPAM	20MG/4ML (5MG/ML)	GEL;RECTAL	Prescription	No	AB	091076	NOVEL LABS INC

GEL;RECTAL; 10MG/2ML (5MG/ML)
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
DIASTAT ACUDIAL	DIAZEPAM	10MG/2ML (5MG/ML)	GEL;RECTAL	Prescription	Yes	AB	020648	BAUSCH
DIAZEPAM	DIAZEPAM	10MG/2ML (5MG/ML)	GEL;RECTAL	Prescription	No	AB	091076	NOVEL LABS INC

Top